Hostname: page-component-7479d7b7d-m9pkr Total loading time: 0 Render date: 2024-07-12T06:33:03.753Z Has data issue: false hasContentIssue false

School Children with ADHD - Effects of Once-dealy OROS Methylphenidate Treatment ADHD Symptoms Included Improvement Academic Functioning

Published online by Cambridge University Press:  16 April 2020

J. Djurkovic-Lazic
Affiliation:
Institut for Psychophisiological and Speach Pathology, Belgrade, Serbia
B. Lazic
Affiliation:
Department of Psychiatry, General Hospital, Sabac, Serbia
N. Milojevic
Affiliation:
Institut for Psychophisiological and Speach Pathology, Belgrade, Serbia
D. Djuric
Affiliation:
Faculty of Medicine, Kragujevac, Serbia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Many well known studies have defined results and tolerability of stimulants used in school children with ADHD in last period. In our follow-up study from August 2007 to January 2009. will present results of once-daily OROS Methylphenidate therapy including break it for holiday.

Method:

We are enrolling 32 children in study, 7-14 years old, and all of them were team-diagnosed according DSM IV/psychiatrist, psychologist, neurologist. Children with ADHD symptoms are treating with OROSMPH (18-54mg), with adjustments based on clinical symptoms, and all ADHD symptoms measures, vital signs, EEG and laboratory results also will be included through our study period.

Results:

Effects of OROS MPH therapy will be presented only in children who completed the study, looking for adverse events, clinically significant effects on vital sings, EEG, laboratory test parameters, and also, improvement academic functions, before and after breaking therapy.

Conclusions:

Besides our expecting on reduction of ADHD symptoms with minimal effects on vital sings,values on growth, tick, laboratory test, it considers too, better academic functioning, social relationship with continual therapy.

Type
P01-08
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.